['Terlipressin is recommended as a gold standard to treat hepatorenal syndrome complicating liver cirrhosis. It is presented as a specific V1A receptor agonist, beyond its enzymatic conversion into lysine'] Is terlipressin , a vasoactive prodrug recommended in hepatorenal syndrome , an agonist of human V1 , V2 and V1B receptors : Implications for its safety profile?